QSI (Quantum-Si incorporated) Stock Financials & Earnings | Market Cap Arena

QSI (Quantum-Si incorporated) Stock Financials & Earnings | Market Cap Arena

QSIQuantum-Si incorporated

Mkt Cap$212M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$2M

Net Income (TTM)-$101M

EPS (TTM)-$0.52

Free Cash Flow (TTM)-$97M

Gross Margin47.3%

Op. Margin-4766.0%

Net Margin-4160.1%

FCF Margin-3991.5%

P/S Ratio (TTM)87.1x

P/E Ratio (TTM)—

YoY Rev Growth-20.3%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$254K	$124K	-$29M
Q2 23	$205K	$78K	-$27M
Q3 23	$223K	$108K	-$27M
Q4 23	$400K	$178K	-$28M
Q1 24	$457K	$269K	-$23M
Q2 24	$622K	$354K	-$26M
Q3 24	$787K	$367K	-$28M
Q4 24	$1M	$610K	-$31M
Q1 25	$842K	$486K	-$25M
Q2 25	$591K	$351K	-$30M
Q3 25	$552K	$194K	-$40M
Q4 25	$451K	$122K	-$21M

Valuation

Quarter	P/S	P/E
Q1 23	835.3x	—
Q2 23	462.3x	—
Q3 23	311.1x	—
Q4 23	196.1x	—
Q1 24	165.1x	—
Q2 24	124.7x	—
Q3 24	93.6x	—
Q4 24	69.4x	—
Q1 25	61.6x	—
Q2 25	62.2x	—
Q3 25	66.8x	—
Q4 25	87.1x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$29M	-$32M
Q2 23	-$23M	-$24M
Q3 23	-$21M	-$23M
Q4 23	-$21M	-$21M
Q1 24	-$23M	-$24M
Q2 24	-$19M	-$20M
Q3 24	-$23M	-$24M
Q4 24	-$23M	-$24M
Q1 25	-$26M	-$27M
Q2 25	-$20M	-$21M
Q3 25	-$32M	-$33M
Q4 25	-$16M	-$16M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$3M
Q2 23	$801K
Q3 23	$1M
Q4 23	$367K
Q1 24	$1M
Q2 24	$1M
Q3 24	$975K
Q4 24	$1M
Q1 25	$1M
Q2 25	$327K
Q3 25	$900K
Q4 25	$17K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	—	+8.6%
Q2 23	—	-10.3%
Q3 23	—	-0.9%
Q4 23	—	-27.2%
Q1 24	+79.9%	-19.2%
Q2 24	+203.4%	-0.1%
Q3 24	+252.9%	+5.4%
Q4 24	+198.0%	+12.7%
Q1 25	+84.2%	+9.0%
Q2 25	-5.0%	+13.4%
Q3 25	-29.9%	+39.7%
Q4 25	-62.2%	-32.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$4M	1538.6%
Q2 23	$2M	909.8%
Q3 23	$1M	511.7%
Q4 23	$2M	400.5%
Q1 24	$2M	360.0%
Q2 24	$2M	390.0%
Q3 24	$2M	306.4%
Q4 24	$2M	201.8%
Q1 25	$2M	280.5%
Q2 25	$3M	490.0%
Q3 25	$3M	512.1%
Q4 25	$3M	596.0%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 23	$18M	$11M
Q2 23	$16M	$11M
Q3 23	$17M	$11M
Q4 23	$16M	$12M
Q1 24	$12M	$12M
Q2 24	$14M	$12M
Q3 24	$16M	$12M
Q4 24	$17M	$14M
Q1 25	$14M	$12M
Q2 25	$15M	$12M
Q3 25	$14M	$11M
Q4 25	$11M	$10M

Revenue Segments

Quarter	Product	Service
Q1 23	$251K	$3K
Q2 23	$187K	$18K
Q3 23	$216K	$7K
Q1 24	$428K	$29K
Q2 24	$584K	$38K
Q3 24	$764K	$23K
Q1 25	$808K	$34K
Q2 25	$558K	$33K
Q3 25	$505K	$47K
Q4 25	$415K	$36K

Revenue by Geography

Quarter	Domestic	International	Non-US	United States
Q3 23	$209K	$14K	—	—
Q2 24	—	—	$400K	$200K
Q3 24	—	—	$400K	$400K
Q1 25	—	—	$719K	$123K
Q2 25	—	—	$435K	$156K
Q3 25	—	—	$341K	$211K
Q4 25	—	—	$242K	$209K

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$82M	$240M	$322M
Q2 23	$88M	$209M	$297M
Q3 23	$94M	$181M	$275M
Q4 23	$134M	$124M	$258M
Q1 24	$53M	$182M	$235M
Q2 24	$60M	$159M	$218M
Q3 24	$42M	$154M	$196M
Q4 24	$49M	$160M	$210M
Q1 25	$37M	$195M	$233M
Q2 25	$22M	$192M	$214M
Q3 25	$31M	$195M	$226M
Q4 25	$22M	$141M	$163M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	140M	+0.3%
Q2 23	142M	+0.9%
Q3 23	142M	+0.1%
Q4 23	142M	-0.1%
Q1 24	142M	+0.1%
Q2 24	142M	+0.1%
Q3 24	142M	+0.3%
Q4 24	146M	+2.8%
Q1 25	182M	+24.6%
Q2 25	184M	+0.7%
Q3 25	209M	+13.8%
Q4 25	198M	-5.4%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 19	—	—
FY 20	$0	2
FY 21	$0	153
FY 22	$0	202
FY 23	$7K	165
FY 24	$21K	143
FY 25	$18K	138